Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

Primary Clinic (Direct GLP) vs Vaylen

Primary Clinic (Direct GLP)
Graded #219

Lower grade

vs+12.400000000000006
Vaylen
Graded #44

Higher grade

The verdict

Vaylen takes it — 77.9/100 to 65.5/100.

Vaylen grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. Vaylen is a pure GLP-1 specialist offering compounded semaglutide ($179/mo), compounded tirzepatide ($239/mo), compounded oral GLP-1 ($259/mo), and brand-name Ozempic, Zepbound, and Wegovy.

We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.

Factor by factor

The same six graded dimensions, side by side. See the methodology.

Cost valueVaylen +2
65
67
Dose & formulationVaylen +34
54
88
Clinical oversightVaylen +9
75
84
Labs & monitoringVaylen +1
76
77
FulfillmentVaylen +17
73
90
Contract termsVaylen +14
41
55
Primary Clinic (Direct GLP) · left barVaylen · right bar

The numbers

MetricPrimary Clinic (Direct GLP)Vaylen
WeighScore65.5/10077.9/100
GradeCC+
Scorecard rank#219#44
Semaglutide$85/mo (0.25-0.75 mg band, membership required, compounded)$179/mo (compounded)
Tirzepatide$133/mo (1.25-2.5 mg band, membership required, compounded)$239/mo (compounded)
Coverage10 statesAll 50 states
Brand-name accessCompounded onlyYes
Oral / sublingualInjection onlyYes

Strengths

  • Direct Primary Care model integrates GLP-1 with continuous primary care — unlike most direct-to-consumer platforms
  • GLP-1 at wholesale cost with no markup — semaglutide from $65/mo, tirzepatide from $110/mo (members only)
  • Unlimited primary care visits, direct text access, and same-day care bundled in the $89/mo membership
  • Routine labs and thousands of medications included in membership — no surprise bills
  • Per-dose pricing shown publicly for all 8 dose tiers of both semaglutide and tirzepatide

Where it loses points

  • The medication price is on top of an $89/mo direct-primary-care membership, which the FAQ states does not include the drug — all-in is about $174/mo for semaglutide and $222/mo for tirzepatide
  • Prices are published as dose BANDS rather than per dose, and the cheapest tirzepatide band starts at 1.25 mg, below the 2.5 mg labelled starting dose
  • The pricing is rendered entirely in JavaScript, so nothing on the page is readable without running the site's bundle
  • Compounded semaglutide and tirzepatide are not FDA-approved finished products
Vaylen

Graded #44 · C+

Strengths

  • Pure GLP-1 specialist — not a multi-category telehealth platform
  • All 50 states coverage with licensed clinicians
  • Both compounded and brand-name options (Ozempic, Wegovy, Zepbound)
  • Oral GLP-1 option (compounded dissolvable tablets) for needle-averse patients
  • LegitScript certified

Where it loses points

  • Compounded semaglutide at $179/mo is mid-range (not the cheapest)
  • Brand-name options at near-retail pricing ($997-$1,086/mo)

Also worth a look

Neither is our top-graded pick — CoreAge Rx leads the scorecard

Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.

Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.

← Back to the scorecard